Page last updated: 2024-10-28

hydroxyurea and Diffuse Large B-Cell Lymphoma

hydroxyurea has been researched along with Diffuse Large B-Cell Lymphoma in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19906 (66.67)18.7374
1990's2 (22.22)18.2507
2000's0 (0.00)29.6817
2010's1 (11.11)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zhao, Y1
Maule, J1
Li, Y1
Neff, J1
McCall, CM1
Hao, T1
Yang, W1
Rehder, C1
Yang, LH1
Wang, E1
ORIGENES, ML1
BEATTY, EC1
BRUBAKER, C1
HAMMOND, D1
HARTMANN, JR1
SHORE, N1
WILLIAMS, KO1
DAVIS, P1
Chamberlain, MC1
Pocsik, E1
Mihalik, R1
Penzes, M1
Loetscher, H1
Gallati, H1
Aggarwal, BB1
Hahn, MA1
Adamson, RH1
Mathé, G1
Schneider, M1
Schwarzenberg, L1
Cattan, A1
Amiel, JL1
Schlumberger, JR1
Stutzman, L1
Creasey, WA1
Capizzi, RL1
DeConti, RC1

Trials

2 trials available for hydroxyurea and Diffuse Large B-Cell Lymphoma

ArticleYear
Combined radiotherapy and chemotherapy of lymphomas and other cancers.
    Cancer research, 1971, Volume: 31, Issue:11

    Topics: Clinical Trials as Topic; Cyclophosphamide; Dactinomycin; Fluorouracil; Follow-Up Studies; Hematopoi

1971
Clinical and biochemical studies of high-dose intermittent therapy of solid tumors with hydroxyurea (NSC-32065).
    Cancer chemotherapy reports, 1970, Volume: 54, Issue:3

    Topics: Adult; Aged; Blood Urea Nitrogen; Chondrosarcoma; Clinical Trials as Topic; Depression, Chemical; DN

1970

Other Studies

7 other studies available for hydroxyurea and Diffuse Large B-Cell Lymphoma

ArticleYear
Sequential development of human herpes virus 8-positive diffuse large B-cell lymphoma and chronic myelomonocytic leukemia in a 59 year old female patient with hemoglobin SC disease.
    Pathology, research and practice, 2019, Volume: 215, Issue:12

    Topics: Antisickling Agents; Cell Transformation, Neoplastic; Disease Progression; Fatal Outcome; Female; He

2019
TRIAL OF HYDROXYUREA (NSC-32065) IN CANCER IN CHILDREN.
    Cancer chemotherapy reports, 1964, Volume: 37

    Topics: Antineoplastic Agents; Busulfan; Child; Cyclophosphamide; Dactinomycin; Humans; Hydroxyurea; Leukemi

1964
PHASE II STUDIES OF HYDROXYUREA (NSC-32065) IN ADULTS: MULTIPLE MYELOMA AND LYMPHOMA.
    Cancer chemotherapy reports, 1964, Volume: 40

    Topics: Antineoplastic Agents; Drug Therapy; Hodgkin Disease; Hydroxyurea; Leukopenia; Lymphoma; Lymphoma, L

1964
Long survival in patients with acquired immune deficiency syndrome-related primary central nervous system lymphoma.
    Cancer, 1994, Mar-15, Volume: 73, Issue:6

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Combined Modality Therapy; C

1994
Effect of cell cycle on the regulation of the cell surface and secreted forms of type I and type II human tumor necrosis factor receptors.
    Journal of cellular biochemistry, 1995, Volume: 59, Issue:3

    Topics: Cell Cycle; Demecolcine; DNA; Enzyme Inhibitors; Etoposide; G1 Phase; G2 Phase; HeLa Cells; Humans;

1995
Pharmacology of 3,5-diamino-1,24-triazole (guanazole). 1. Antitumor activity of guanazole.
    Journal of the National Cancer Institute, 1972, Volume: 48, Issue:3

    Topics: Amines; Animals; Antineoplastic Agents; Carcinoma 256, Walker; Cyclophosphamide; Cytarabine; Depress

1972
[Personal experience on the chemotherapy of leukemias and hematosarcomas].
    Acta geneticae medicae et gemellologiae, 1968, Volume: 17, Issue:1

    Topics: Antineoplastic Agents; Drug Synergism; Hodgkin Disease; Humans; Hydrazines; Hydroxyurea; Leukemia; L

1968